Aspen Neuroscience
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
10835 Road To the Cure Ste 100, San Dieg...Phone Number
(858) 263-1222Website
www.aspenneuroscience.comRevenue
-Industry
About Aspen Neuroscience
Aspen Neuroscience, Inc. is a clinical-stage, regenerative medicine biotechnology company headquartered in San Diego, California, focused on developing autologous induced pluripotent stem cell therapies to address neurodegenerative diseases. Founded in 2018, the company's lead program is an investigational patient-specific cell therapy for Parkinson's disease, designed to replace lost dopamine neurons with dopaminergic neuron precursor cells derived from the patient's own cells, combining stem cell biology, genomics, and bioinformatics to deliver personalized regenerative treatments.Explore more
Aspen Neuroscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Aspen Neuroscience
Compare insights from companies similar to Aspen Neuroscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Aspen Neuroscience Tech Stack
A closer look at the technologies used by Aspen Neuroscience
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aspen Neuroscience
Sign Up For FreeTo access detailed company insights
Aspen Neuroscience, Inc. is a clinical-stage, regenerative medicine biotechnology company headquartered in San Diego, California, focused on developing autologous induced pluripotent stem cell therapies to address neurodegenerative diseases. Founded in 2018, the company's lead program is an investigational patient-specific cell therapy for Parkinso... Read More
